Shocking news for India amid rising corona cases, AstraZeneca suspends vaccine testing

London, Ta. 09 September 2020 Wednesday

Amid the threat of the corona virus, the American AstraZeneca began testing the vaccine. However now that testing has been discontinued. AstraZeneca has postponed its last phase of vaccine testing.

A volunteer who fell ill during a human test of the vaccine was found to have stopped testing by AstraZeneca. AstraZeneca has issued a statement saying that this is a routine hurdle as no further information has yet been obtained regarding the illness of the person involved in the test. It will be systematically reviewed and only then will the trial be resumed.

There has been a major setback to developing a vaccine against coronavirus. The trials of AstraZeneca and Oxford University vaccine men have been postponed after one person fell ill.

AstraZeneca said this is a routine disruption, as nothing is yet understood about the illness of the person involved in the test. The trial of the corona virus vaccine has stopped at Oxford University for the second time. The vaccine was named AZD1222. According to the World Health Organization, it was at the forefront of other vaccine trials in the world.

Many countries, including India, are monitoring the Oxford University vaccine. Experts believe there is much hope that Oxford University will be involved in the first vaccine to hit the market.

Ongoing experiments have been stopped all over the world and can now be resumed only after an independent investigation. The third phase of the vaccine trial involves thousands of people, and it often seems. The third phase of corona vaccine testing involved about 30,000 people.

At the forefront of the global race for the AstraZeneca Corona vaccine

According to the Health News website, one of the volunteers who took part in the trial has seen suspicious adverse reactions to the vaccine and in view of this it has been decided to block the trial of the last phase of the vaccine.

AstraZeneca Corona, a company that develops vaccines in collaboration with Oxford University, is at the forefront of the global vaccine race. Corona vaccine races also include Johnson & Johnson, Merck & Co., Modernna Inc., Novavex Inc., Sanofi, Fizer, GlaxoSmithKline, Bayonet, and more.